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ing activity of BH3-only protein Bim can be reconstituted in yeast when both Bax and antiapoptotic
protein Bcl-XL are present, suggesting that Bim likely activates Bax indirectly by inhibiting antiapo-
ptotic proteins.
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In mammalian cells, two major apoptotic pathways – the
extrinsic and the intrinsic – are activated in response to either
external or internal apoptotic stimuli, respectively. The proteins
of the Bcl-2 family are key regulators of intrinsic (also known as
mitochondrial) pathway [1]. They integrate diverse pro-death sig-
nals and translate them into the single universal death-inducing
event – the release of cytochrome c from mitochondria, which is
considered a commitment point of the pathway [2]. The family
consist of both proapoptotic proteins, which promote the release
of cytochrome c and antiapoptotic proteins that inhibit the release
of cytochrome c frommitochondria. All family members share a se-
quence homology in up to four homologous regions – Bcl-2 homol-
ogy domains (BH1-BH4). Based on their activity and presence of BH
domains Bcl-2 proteins can be divided into three subfamilies.
While multi-domain proapoptotic members of the family – Bax
and Bak, which contain three BH domains (BH1-BH3), are the ac-
tual executioners of cytochrome c release as they participate atchemical Societies. Published by E
nnel; SC, synthetic complete
ogy domainthe creation of a pore in outer mitochondrial membrane, their
activity is regulated by other two subfamilies. Antiapoptotic sub-
family of proteins containing all four BH domains, such as Bcl-XL
and Bcl-2, inhibit their pore-formation activity and proapoptotic
members referred to as ‘BH3-only’ subfamily, since they contain
only BH3 domain, stimulate their activity in response to diverse
proapoptotic stimuli [3].
Bim is one of the BH3-only proteins involved in the apoptosis
induced by stimuli, such as antigen receptor ligation, Ca2+ ﬂux,
UV irradiation or taxol treatment. In living cells, Bim is sequestered
to cytoskeleton by binding to the light chain of the dynein [4] and
upon apoptotic stimulus it is released from the complex and acti-
vates the formation of the pore in the mitochondrial membrane
by Bax or Bak. The controversy remains on whether Bim and other
BH3-only proteins induce formation of the pore by directly activat-
ing multi-domain proapoptotic proteins (Bax, Bak) or whether they
rather inhibit the antiapoptotic proteins (e.g., Bcl-XL, Bcl-2).
Several isoforms of Bim are produced by alternative splicing of
the Bim transcript. The longest form BimEL is produced from unsp-
liced mRNA, while in other isoforms, e.g., BimL and BimS, excision
of introns results in internal deletions [5]. Isoforms of Bim differ
in the pro-death potency with short isoform (BimS) being the most
and extra long isoform (BimEL) being the least potent. The different
potency of these proteins may be due to different regulation oflsevier B.V. All rights reserved.
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that potentially interact with other proteins, for example the ab-
sence of the dynein binding domain in BimS.
Although yeast do not have homologues of Bcl-2 proteins, it’s
been shown that yeast Saccharomyces cerevisiae can be used as a
simple model system, in which to study the action of both multi-
domain proapoptotic and antiapoptotic members in the Bcl-2 fam-
ily following their ectopic expression. Expression of proapoptotic
protein Bax in yeast results in permeabilization of mitochondrial
membranes, release of cytochrome c and ultimately to cell death
[6,7]. Coexpression of antiapoptotic protein Bcl-XL, on the other
hand, suppresses the action of Bax on mitochondrial membrane
and rescues cells from Bax induced cell death [7]. In order to ad-
dress the questions of mechanisms that underlie the action of
Bim, we have extended this model system by introducing ‘BH3-
only’ protein Bim.
2. Materials and methods
2.1. Strains, plasmids and growth conditions
The yeast strains used throughout this study are CML282 (MATa
ura3-1, ade2-1, leu2-3,112, his3-11,15, trp1-D2, can1-100, CMVp
(tetR-SSN6)::LEU2) [8], CML282/GAL-BAX [9] and CML282/GAL-
BAK [10]. Latter two strains contain coding sequence of murine
Bax or Bak N-terminally tagged with HA epitope, downstream from
GAL1/10 promoter, integrated into genomic HIS3 locus in CML282
background. Versions of these strains with POR1 gene deleted
(CML282Dpor1, CML282Dpor1/GAL-BAX and CML282Dpor1/GAL-
BAK) were generated as described earlier [9].
Cells were grown on synthetic complete media (SC) containing
the indicated carbon sources and lacking appropriate amino acids.
Yeast were transformed by standard lithium acetate protocols [11].
To express BimEL, sequences encoding murine Bim were ampli-
ﬁed by PCR using 50-AGTCGGATCCATGGCCAAGCAACCTTCTGA-30
and 50-CTGAGAATTCAAGCTTGATCCTGTCAATGCCTTCTC-30 prim-
ers, cleaved with BamHI and EcoRI and subcloned into YCp-type
vector p416MET25 downstream of theMET25 promoter [12]. From
resulting plasmid (p416MET-BIMEL), analogous plasmid contain-
ing BimS (p416MET-BIMS) was prepared by PCR (50 phosphory-
lated 50-GCTTCCATACGACAGTCTCAG-30 and 50-TTGCGGTTCTGT
CTGTAGGGA-30 as primers) and ligation of ends of generated
product.
To assess the growth potential of individual strains, cells were
grown overnight in 2% glucose containing media, diluted to
A600 = 0.5 and 10 ll of serial 5-fold dilutions were spotted on test
plates. Growth was assessed following incubation at 28 C for
3 days.
To assess growth of yeast in liquid culture a procedure de-
scribed in Weber et al. [19] was followed. Brieﬂy, cells grown in
SC (2% glucose) were resuspended in SC containing 2% rafﬁnose
and 0.1% galactose and no methionine to induce expression of
Bax and Bim, diluted to A600 = 0.1 and cultivated at 28 C. A600
was measured at indicated time points. To assess the viability, at
corresponding times, aliquots containing 500 cells were plated
on solid YPD (1% yeast extract, 2% peptone, 2% glucose) media. Col-
onies were counted after 3 days at 28 C.
2.2. Preparation of protein extracts, immunoblotting and cell
fractionation
Protein extracts were prepared by alkaline lysis and trichloro-
acetic acid (TCA) precipitation [13], separated by electrophoresis
on 12.5% SDS–polyacrylamide gels and transferred to nitrocellu-
lose membrane by electroblotting. Antibodies used for proteindetection were a mouse monoclonal directed against the HA epi-
tope (F-7, Santa Cruz Biotechnology), OxPhos Complex IV subunit
II (COXII, Molecular Probes), phosphoglycerate kinase (Molecular
Probes) and rabbit polyclonal against Bim/BOK (Chemicon Interna-
tional). Immunoblots were incubated with appropriate HRP-conju-
gated secondary antibodies (Promega) and binding visualized
using a chemiluminescent substrate (Pierce).
Mitochondria were prepared as described previously [14,15].
Brieﬂy, cells were converted to spheroplasts by enzymatic diges-
tion with Zymolyase 20T (Seikagaku Kogyo) and homogenized
with a glass-teﬂon homogenizer. The homogenate was centrifuged
at 3000g, and the resulting supernatant centrifuged at 10 000g
to pellet heavy membranes enriched in mitochondria. The super-
natant from this centrifugation was recentrifuged at 10 000g
and subsequent supernatant containing the cytosol loaded on to
SDS–polyacrylamide gels. The heavy membrane fraction was
washed with homogenization buffer prior to separation on SDS–
PAGE.
For alkali treatment, the mitochondrial pellet was resuspended
at 0.25 mg protein/ml in freshly prepared 0.1 M sodium carbonate,
pH 11.5, and incubated on ice for 30 min. Membranes were pel-
leted by centrifugation at 150 000g while proteins removed from
mitochondria by alkali treatment were precipitated from the
supernatant by addition of TCA to 7%, centrifuged, and washed
with acetone. Both alkali-extracted proteins and membrane frac-
tions were analyzed by SDS–PAGE and Western blotting.
3. Results and discussion
In mammalian cells, Bim and other BH3-only proteins sense the
state of the cell and trigger Bax and Bak to induce the release of
cytochrome c from mitochondria upon various signals. The mech-
anism of the activation of Bax and Bak by Bim, however, remains
under dispute. Some data indicate that at least some of the BH3-
only proteins, including Bim, may induce oligomerization of Bax
and a translocation of Bax to the mitochondria directly [16,17].
This would involve the physical binding of the BH3-only protein
to the inactive cytosolic Bax, inducing a conformational change
that would enable not only mitochondrial translocation of Bax
but also oligomerization of Bax once inserted into mitochondrial
membranes or Bak. In contrast, other data indicate that BH3-only
proteins can bind antiapoptotic Bcl-2 family members, such as
Bcl-XL and Bcl-2, inhibiting their ability to counter the actions of
proapoptotic family members like Bax and Bak, resulting in the
activation of these proapoptotic molecules indirectly [18].
In order to investigate the mechanisms involved in proapoptotic
action of BH3-only protein Bim, we have expressed the murine Bim
in yeast S. cerevisiae. First we have transformed common yeast
strain, CML282, with plasmids containing coding sequence of mur-
ine Bim gene downstream of MET25 promoter and assessed the
viability of resulting strain expressing Bim. As shown in Fig. 1b,
protein of appropriate molecular weight corresponding to BimEL
isoform was expressed. Expression of Bim did not have any effect
on viability of the yeast strain expressing protein as compared to
the strain transformed with the control plasmid (Fig. 1a) and no
other evident phenotype has been observed in this strain. Since
in mammalian cells Bim regulates apoptosis by modulating activity
of other Bcl-2 family members, we have tested the ability of Bim to
modulate the death- or survival-promoting activity of Bax and Bcl-
XL, respectively. To ﬁnd out whether Bim modulates activity of Bax
directly we have assessed the viability of yeast strains expressing
both Bim and Bax. As described earlier [9], amount of Bax protein
expressed in these strains is proportional to the concentration of
galactose in media. In yeast strains expressing Bax, viability was
dramatically compromised on the media with concentration of
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Fig. 2. Expression of Bim inhibits pro-survival activity of Bcl-XL. (a) CML282/GAL-BAX cells transformed with TET-BCL-XL plasmid together with either p416MET-BimEL or
empty vector were cultivated in glucose media and cell suspensions were spotted onto SC plates containing indicated carbon source and concentration of doxycycline.
Growth was assessed after 3 days. (b) Expression of BimEL, Bax, Bcl-XL and phosphoglycerate kinase (Pgk, a loading control) under relevant cultivation conditions was
detected by immunoblotting.
BimEL 
control
glucose + Met  2 % galactose - Met
a b
c d
co
ntr
ol
Bim
EL
 
Pgk
25 kDa
15 kDa
BimEL
Bax
Bax + BimEL
Bax + Bcl-XL
esotcalag % 2 esoculg 0.1 % galactose
2 % raffinose
Ba
x
Ba
x +
 Bi
m E
L 
glucose  2 % gal.
0.1 % gal.
2 % raff.
Pgk
HABax
BimEL
Ba
x
Ba
x +
 Bi
m E
L 
Ba
x
Ba
x +
 Bi
m E
L 
Fig. 1. Expression of Bim has no effect on growth of wild type and Bax-expressing yeast cells. (a) CML282 cells transformed with p416MET-BimEL (BimEL) or empty vector
(control) were cultivated in glucose media and cell suspensions were spotted onto SC plates containing indicated carbon source with or without methionine to repress or to
derepress the MET-BimEL, respectively. Growth was assessed after 3 days. (b) Expression of BimEL and phosphoglycerate kinase (Pgk, a loading control) was detected by
immunoblotting. (c) CML282/GAL-BAX cells transformed with p416MET-BimEL (Bax+BimEL) or empty vector (Bax) were cultivated in glucose media and cell suspensions
were spotted on SC plates containing indicated carbon source. Medium was supplemented with 2 lg/ml doxycycline to support viability of control strain CML282-BAX-BCLXL
(Bax+Bcl-XL). Growth was assessed after 3 days. (d) Expression of BimEL, Bax and phosphoglycerate kinase (Pgk, a loading control) under relevant cultivation conditions was
detected by immunoblotting.
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increase the sensitivity of yeast towards Bax mediated killing, as
shown by unchanged viability of strains expressing Bax and Bim
compared to strains expressing Bax alone, on any concentration
of galactose, especially in the range close to 0.1% (Fig. 1c), indicat-
ing that in this experimental setting Bim does not potentiate the
action of Bax by direct interaction.
To test whether Bim is able to inhibit antiapoptotic activity of
Bcl-XL, we have tested the effect of expression of Bim on cellsurvival of yeast strains coexpressing Bax and Bcl-XL. The viability
of strains expressing Bax and Bcl-XL either together with Bim or
without Bim was assessed by spotting serial dilutions of cells to
plates with 2% galactose and various increasing concentration of
doxycycline. Strains, in which no Bim was expressed, maintained
growth on plates with concentration of doxycycline of 0.1 lg/ml
and higher due to sufﬁcient expression of antiapoptotic Bcl-XL
[9]. Decrease of viability of strains expressing Bim was observed
as compared to strains without Bim (Fig. 2). Effect of Bim became
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Fig. 3. BimEL is integrated into mitochondrial membrane. CML282 cells harboring
p416MET-BimEL, TET-BCL-XL plasmids or respective empty vectors were grown in
SC (0.25% glucose) without methionine (to support the expression of BimEL)
supplemented with 2 lg/ml doxycycline (to support the expression of Bcl-XL),
converted to spheroplasts, homogenized and separated into soluble cytosolic and
heavy-membrane fractions enriched in mitochondria by differential centrifugation.
Fifty micrograms of protein of each fraction were separated by SDS–PAGE.
Mitochondrial fractions were subjected to extraction with 0.1 M sodium carbonate
pH 11.5 and membranes were pelleted by centrifugation. Supernatants and pellets
generated from 50 lg of total mitochondrial protein were separated by SDS–PAGE.
Immunoblots were probed with antibodies directed to the BimEL, HA (HA-Bcl-XL)
and CoxII (inner mitochondrial membrane integral protein).
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thus increasing amount of Bcl-XL protein expressed. Essentially
same results were obtained with yeast strain coexpressing proa-
poptotic protein Bak instead of Bax and antiapoptotic Bcl-2 instead
of Bcl-XL (Supplementary Fig. 1).
As these ﬁndings seemed to contradict the observation that
expression of Bim (short isoform BimS) interferes with growth of
yeast strain expressing Bax in the absence of antiapoptotic protein
(e.g., Bcl-XL or Bcl-2) when growth is assessed in liquid culture
[19], we tested the growth of strain coexpressing BimEL and Bax,
as well as strain coexpressing BimS together with Bax, in the same
experimental setting as described in Weber et al. [19]. In this
experiment, we have not observed any signiﬁcant effect of expres-
sion of either BimEL or BimS on the growth of cell culture whenBax
Bax + BimEL
Bax + Bcl-XL
Bax + Bcl-XL + BimEL
glucose
0.1
Fig. 4. Mitochondrial VDAC is not required for activity of BimEL. CML282/Dpor1/GAL-BA
empty vector were cultivated in glucose media and cell suspensions were spotted onto p
was assessed after 3 days.these were coexpressed with Bax (Supplementary Fig. 2a). At each
time point we have also tested the viability of the cultures. Cul-
tures coexpressing either isoform of Bim with Bax consisted of
equal portion of viable cells as strain expressing Bax alone (Supple-
mentary Fig. 2b), indicating that coexpression of Bim and Bax in
this setting does not affect neither the growth rate nor the viability
of yeast.
Results described above demonstrated that when murine Bim
together with Bax and Bcl-XL were expressed in yeast, Bim was
able to inhibit antiapoptotic activity of Bcl-XL while it did not
potentiate the proapoptotic activity of Bax (or Bak) when no anti-
apoptotic proteins were present. While this favorizes indirect mod-
el of Bax activation by Bim over the direct model, the latter cannot
be disproved completely as Bax expressed in yeast exhibits a cell
killing activity even when no other Bcl-2 family members are pres-
ent, indicating that it is at least partially active already.
To examine cellular localization of Bim, the cytosolic fraction
and heavy-membrane fraction enriched in mitochondria were iso-
lated from yeast strains expressing either Bim or Bim together with
Bcl-XL. Western-blot analysis of these fractions showed that in
both strains Bim was present in in mitochondria enriched fraction
resembling the localization of mitochondrial marker CoxII (Fig. 3).
The assessment of the integration of Bim into mitochondrial mem-
branes by alkali treatment demonstrated that, independently on
the presence of Bcl-XL, Bim is integrated into membranes (Fig. 3),
indicating that Bim contains intrinsic mitochondrial membrane
localization signal that targets Bim to mitochondria in the absence
of proteins that sequester Bim in cytosol in mammalian cells (e.g.,
dynein LC8) and that no interaction with Bcl-XL is required for
mitochondrial membrane targeting and integration.
Based on experiments with puriﬁed BimEL and isolated mito-
chondria it has been suggested that Bim induced permeabilization
of mitochondrial membrane is dependent on voltage-dependent
anion channel (VDAC) in the outer mitochondrial membrane
[20]. Although participation of VDAC has also been proposed for
permeabilization of mitochondrial membranes by Bax and Bak, it
has been established that the latter two proteins permeabilize
membrane independently of VDAC [9,21] and that VDAC may par-
ticipate on the permeabilization of mitochondria by another mech-
anism – opening of the mitochondrial permeability transition pore
[22].
To test whether VDAC is required for the inhibitory effect of Bim
on Bcl-XL we have carried out the same set of experiments as those
described above in the isogenic yeast strain with POR1 gene encod-
ing for VDAC deleted (Dpor1). In this strain, Bim had no effect on
viability when expressed alone and did not inﬂuence the survival
of the strain coexpressing Bax. As it did in a wild type yeast strain,
the expression of Bim reduced the viability of the Dpor1 strain
when Bcl-XL and Bax were coexpressed (Fig. 4), clearly indicating
that mitochondrial VDAC is not required for the Bim to induce cell
killing.
Taken together, our experiments in yeast have shown that BH3-
only protein Bim likely activates Bax andBak indirectly by inhibitinggalactose
 µg/ml doxycycline
galactose
2 µg/ml doxycycline
X harboring the TET-BCL-XL plasmid together with either pMET-BimEL plasmid or
lates containing indicated carbon source and concentration of doxycycline. Growth
B. Juhásová et al. / FEBS Letters 585 (2011) 2709–2713 2713antiapoptotic proteins Bcl-XL and Bcl-2, and that the action of Bim
does not appear to be dependent on presence of VDAC in mitochon-
drial membrane.
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